TG Therapeutics Inc. (TGTX) Drops 8.53% on January 27

Equities Staff |

TG Therapeutics Inc. (TGTX) was one of the Russell 2000's biggest losers for Wednesday January 27 as the stock slid 8.53% to $7.94, a loss of $-0.74 per share. Starting at an opening price of $8.62 a share, the stock traded between $7.86 and $8.74 over the course of the trading day. Volume was 239,388 shares over 2,204 trades, against an average daily volume of 617,324 shares and a total float of 52.52 million.

The losses send TG Therapeutics Inc. down to a market cap of $417.01 million. In the last year, TG Therapeutics Inc. has traded between $20.00 and $7.68, and its 50-day SMA is currently $11.46 and 200-day SMA is $13.99.

TG Therapeutics Inc is a biopharmaceutical company. It is engaged in the acquisition, development & commercialization of medically important pharmaceutical products for the treatment of cancer & other underserved therapeutic needs.

TG Therapeutics Inc. is based out of New York, NY and has some 30 employees. Its CEO is Michael S. Weiss.

For a complete fundamental analysis analysis of TG Therapeutics Inc., check out Equities.com’s Stock Valuation Analysis report for TGTX. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

H-Source Holdings Ltd.

H-Source Holdings Inc. is a technology company operating within the healthcare industry through its subsidiary, H-Source, Inc. The Company has developed a transaction platform that provides a private, secure and…

Private Markets

Snapwire

A peer-to-Peer authentic photo marketplace disrupting the $10B commercial photography industry.

Snapchat

Snapchat is the fastest way to share a moment with friends. The mobile app, allows users to not only share photos with friends but also control how long they can…